scholarly journals Higher triglyceride serum level increases atherosclerotic index in subjects 50-70 years of age

2016 ◽  
Vol 34 (3) ◽  
pp. 205
Author(s):  
Martiem Mawi ◽  
Fransisca Chondro ◽  
Juni Chudri
Keyword(s):  
Serum Level ◽  
Total Cholesterol ◽  
Triglyceride Level ◽  
Density Lipoprotein ◽  
Serum Triglyceride ◽  
Hdl Cholesterol ◽  
High Serum ◽  
Atherogenic Index ◽  
Serum Triglyceride Level ◽  
Cross Sectional

Background<br />Atherosclerosis, the underlying cause of heart attack, stroke and peripheral disease, is a main cause of morbidity and mortality worldwide. Hypercholesterolemia and hypertriglyceridemia are independent factors in the development and progression of atherosclerosis. The atherosclerotic index (AI) is a strong indicator of cardiovascular heart disease. The objective of this study was to determine the relationship between lipid serum level and AI in subjects 50-70 years of age. <br /><br />Methods <br />A study of cross-sectional design was conducted among male and female subjects 50-70 years of age. The inclusion criteria were: healthy, and capable of active communication. The exclusion criteria were: subjects not completing the study, currently consuming antihyperlipidemic drugs. Lipid profile comprising total cholesterol, low density lipoprotein (LDL), high density lipoprotein (HDL), triglycerides, and malondialdehyde (MDA), was analyzed using commercial kits. Systolic and diastolic blood pressure and body mass index was measured in all subjects. Atherogenic index was calculated from (total cholesterol – HDL cholesterol) / HDL cholesterol. Multiple linear regression was used to analyze the data.<br /><br />Results <br />Mean age of the subjects was 60.6 ± 3.30 years and there was a significant relationship of LDL cholesterol and triglycerides with AI (b=0.009; p=0.000 and b=0.008; p=0.000, respectively). Triglyceride level was the most influencing factor for AI (b=0.008; Beta=0.616; p=0.000)<br /><br />Conclusions<br />Higher triglyceride levels increase AI in subjects 50-70 years of age. Subjects with high serum triglyceride level but without symptoms of cardiovascular disease should be examined for the development of coronary artery blockage.

scholarly journals Association of Serum Ceruloplasmin Level with Obesity: Some Components of Metabolic Syndrome and High-Sensitive C-Reactive Protein in Iran

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Seyyed Morteza Safavi ◽  
Rahele Ziaei ◽  
Mohammad Reza Maracy
Keyword(s):  
Total Cholesterol ◽  
Triglyceride Level ◽  
Serum Triglyceride ◽  
Positive Association ◽  
Hdl Cholesterol ◽  
Control Group ◽  
Case Group ◽  
Serum Triglyceride Level ◽  
Metabolic Disturbances ◽  
Serum Ceruloplasmin

Background. One of the mechanisms that has been suggested for obesity related metabolic disturbances is obesity-induced inflammation. Pro-inflammatory cytokines generated in adipose tissue can increase hepatic synthesis of inflammation-sensitive plasma proteins (ISPs) including ceruloplasmin (Cp). In this study we aimed to investigate the relation between serum Cp level and obesity.Methods. 61 persons with body mass index (BMI) ≥ 25 kg/m2(case group) and 61 persons with BMI < 25 kg/m2(control group) were included in this study with a case-control design. Serum Cp levels, triglyceride level, fating blood glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol and hsCRP were measured in both groups.Results. We did not observe any significant association between serum Cp level and BMI in all subjects [OR: 1.02 (CI, 0.967 to 1.07)] and in case (β=0.012,P=0.86) and control groups (β=0.49,P=0.07) separately. However, in control group, this positive association was marginally significant. We found a positive correlation between serum Cp level and serum triglyceride level.Conclusion. Serum Cp level was not related to obesity in this group of subjects. None of the baseline variables could predict obesity in this group of subjects, including serum Cp level, FBS, total cholesterol, LDL and HDL- cholesterols and hsCRP.

scholarly journals The Pattern of Common Cholesterol Fractions in Stroke Patients

2021 ◽  
pp. 146-154
Author(s):  
Ijoma Uchenna Nkemdilim ◽  
A. Ezeala-Adikaibe Birinus ◽  
Ekochin Fintan ◽  
Innocent Chukwuemeka Okoye ◽  
Onodugo Nkiru Pauline ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Total Cholesterol ◽  
Serum Cholesterol ◽  
Hemorrhagic Stroke ◽  
Density Lipoprotein ◽  
Hdl Cholesterol ◽  
High Serum ◽  
University Teaching ◽  
Stroke Patients ◽  
Cross Sectional

Aims/Purpose: The aim of this study was therefore to document the frequency and pattern of serum cholesterol in stroke patients admitted in a tertiary hospital in Enugu. Methods: This was a descriptive cross-sectional study carried out at Enugu State University Teaching Hospital Enugu. Serum cholesterol levels were classified based on the current international cut off points for people with cardiovascular disease. Statistical analysis of data was carried out using SPSS version 22. Results: Data from a total of 180 subjects were collected and analyzed. The mean (sd) of serum cholesterol fractions and their distributions are: Low density lipoprotein 2.4± 1.18 mmol/l, High density lipoprotein, 1.17± 0.62 mmol/l, Total Cholesterol, 4.43± 1.34 mmol/l, and triglycerides 1.21±0.77 mmol/L. HDL-cholesterol was significantly lower in patients 50 years and older. P=0.02. A total of 12 (6.7%) of the patients had high levels of LDL, 92(51.1%) had poor levels of HDL. Between stroke types, 10(7.2%) of patients with ischemic stroke had high serum LDL compared to 2(4.8%) with hemorrhagic stroke p= 0.32. Among those with hemorrhagic stroke, 22(52.4%) had poor levels of HDL compared to 70(50.7%) of those with ischemic stroke p= 0.17. Total cholesterol and triglycerides were also found in a higher proportion of those with ischemic stroke than hemorrhagic although these differences were not statistically significant. Conclusions: There mean level of serum LDL, HDL and TC are higher in stroke patients than recommended values. Current recommended universal use of statins after stroke should be encouraged in both ischemic and hemorrhagic stroke.

scholarly journals Normal Non-HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case-Control Study of Tema Metropolis

2016 ◽  
Vol 2016 ◽  
pp. 1-5 ◽  
Author(s):  
Richard K. D. Ephraim ◽  
Patrick Adu ◽  
Edem Ake ◽  
Hope Agbodzakey ◽  
Prince Adoba ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Steady State ◽  
Sickle Cell Disease ◽  
Total Cholesterol ◽  
Sickle Cell ◽  
Density Lipoprotein ◽  
Hdl Cholesterol ◽  
Lipoprotein Cholesterol ◽  
Cell Disease ◽  
Cross Sectional

Background.Abnormal lipid homeostasis in sickle cell disease (SCD) is characterized by defects in plasma and erythrocyte lipids and may increase the risk of cardiovascular disease. This study assessed the lipid profile and non-HDL cholesterol level of SCD patients.Methods.A hospital-based cross-sectional study was conducted in 50 SCD patients, in the steady state, aged 8–28 years, attending the SCD clinic, and 50 healthy volunteers between the ages of 8–38 years. Serum lipids were determined by enzymatic methods and non-HDL cholesterol calculated by this formula: non-HDL-C = TC-HDL-C.Results.Total cholesterol (TC) (p=0.001) and high-density lipoprotein cholesterol (HDL-C) (p<0.0001) were significantly decreased in cases compared to controls. The levels of non-HDL-C, low-density lipoprotein cholesterol (LDL-C), and triglyceride (TG) were similar among the participants. The levels of decrease in TC and HDL were associated with whether a patient was SCD-SS or SCD-SC. Systolic blood pressure and diastolic blood pressure were each significantly associated with increased VLDL [SBP,p=0.01, OR: 0.74 (CI: 0.6–0.93); DBP,p=0.023, OR: 1.45 (CI: 1.05–2.0)].Conclusion.Dyslipidemia is common among participants in this study. It was more pronounced in the SCD-SS than in SCD-SC. This dyslipidemia was associated with high VLDL as well as increased SBP and DBP.

scholarly journals Study on the influence of 7-β-hydroxy-γ-aryloxypropylxanthinyl-8-thioalkanic acid derivatives on the lipid metabolism in experiment

2021 ◽  
Vol 23 (3) ◽  
pp. 411-416
Author(s):  
I. M. Bilai ◽  
M. I. Romanenko ◽  
D. H. Ivanchenko
Keyword(s):  
Side Effects ◽  
Total Cholesterol ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Hdl Cholesterol ◽  
Lipoprotein Cholesterol ◽  
Atherogenic Index ◽  
Low Density ◽  
Low Density Lipoprotein Cholesterol ◽  
Xanthine Derivatives

Statin side effects are not a rare occurrence, in particular dyspeptic disorders, insomnia, headache, skin erythema, rash are often noted. All of this determines scientists to find new effective and low-toxic hypolipidemic agents. Various natural and synthetic xanthine derivatives have been recognized as therapeutically potential compounds and reported to control various diseases. Therefore, the study of new xanthine derivatives and their hypolipidemic effects, which would have a significant therapeutic effect with minimal side effects, is relevant. The aim of the study was to examine the effect of 7-β-hydroxy-γ-aryloxypropylxanthinyl-8-thioalkanic acid derivatives on lipidogram parameters in experimental laboratory rats. Materials and methods. The objects of the study were 7-β-hydroxy-γ-aryloxypropylxanthinyl-8-thioalkanic acid derivatives. The experiments were performed in white laboratory Wistar rats weighing 180–220 g. Experimental modeling of hyperlipidemia – tween model: intraperitoneal administration of tween-80 at a dose of 200 mg/100 g body weight. The test compounds were administered orally, simultaneously with tween, at a dose of 1/10 of LD50 (previously calculated by Prozorovsky express method) for 6 days. The following indicators of lipidogram were determined: total cholesterol (TC), high-density lipoprotein cholesterol (HDL cholesterol), low-density lipoprotein cholesterol (LDL cholesterol), triglycerides (TG) and atherogenic index of plasma: TC – HDL cholesterol / HDL cholesterol. The experiments were carried out with respect to Bioethical rules and norms. Results. The studies have shown data on the hypolipidemic activity of 7-β-hydroxy-γ-aryloxypropylxanthinyl-8-thioalkane acid derivatives. According to the conditional efficiency index Ʃ, which included the overall percentage of the following indicators – total cholesterol, low-density lipoprotein cholesterol and triglycerides, the leading compounds were 2439 (87.47 %), 6047 (82.30 %). The reference drug atorvastatin had a value of 82.98 %. Conclusions. The major compound was 2439 identified among all compared to the control group. The prospect of further research is a more detailed study on the ability of xanthine derivatives to exhibit hypolipidemic effects and to influence oxidative stress in various hyperlipidemic models.

scholarly journals Evaluation of Serum Triglyceride and Total Cholesterol Status in Adolescent Smoker

1970 ◽  
Vol 1 ◽  
pp. 14-18
Author(s):  
L Afrin ◽  
R Sultana ◽  
S Ferdousi ◽  
A Ahmed ◽  
MR Amin
Keyword(s):  
Total Cholesterol ◽  
Serum Lipid ◽  
Serum Triglyceride ◽  
Adolescent Male ◽  
Serum Triglyceride Level ◽  
Cross Sectional ◽  
Cholesterol Levels ◽  
Increased Risk ◽  
The Mean ◽  
Dose Response Effect

Objectives: A cross sectional comparative study was performed to evaluate the changes of the serum lipid profile in apparently healthy adolescent male non smokers and smokers’ subjects. Method: This study was carried out in the department of Physiology of Dhaka Medical College from January to December 2005. For this purpose, total 80 subjects with age range 12-19 years were selected, of whom 20 were non smokers (control) and 60 were smokers (experimental) who smoked for at least one year. Again smokers were grouped according to the number of cigarettes smoked per week, ( mild < 19, moderate 20-59, heavy >60). Fasting serum Triglyceride and total Cholesterol levels of all subjects were measured. Data were compared between smokers and non smokers and between non smoker and mild moderate and heavy smokers and analyzed statistically by unpaired t test. Result: Mean ±SD Triglyceride levels were136.80mg/dl ± 42.18 vs. 153.12mg/dl ± 26.66 and Mean ±SD Total Cholesterol levels were 165.20mg/dl ± 15.13 vs165.36mg/dl ± 10.12 in non smokers and smokers respectively. there were no significant changes in the mean serum total cholesterol levels in adolescent smokers but the mean serum triglyceride level in smokers were significantly higher (p<0.01 )than that of non smokers. hyper Triglyceridemia (TG level> 150mg/dl) were observed in 56% of smoker subjects whereas 36% in non smokers. The dose response effect of smoking was observed in serum triglyceride levels of smoker subgroups. Mean ±SD TG levels in mild, moderate, heavy groups were 148.15mg/dl± 21.32,152.8mg/dl± 29.49,154.12mg/dl± 23.75 respectively. Conclusion: From the result of the present study it may be concluded that, cigarette smoking during adolescent period induces alteration in serum lipid levels in the direction of increased risk for coronary artery disease. J Bangladesh Soc Physiol. 2006 Dec;(1):14-18

scholarly journals Lipid profiles in smoking and non-smoking male adolescents

2014 ◽  
Vol 54 (4) ◽  
pp. 232
Author(s):  
Sigit Prastyanto ◽  
Mei Neni Sitaresmi ◽  
Madarina Julia
Keyword(s):  
Total Cholesterol ◽  
Tobacco Smoking ◽  
Ldl Cholesterol ◽  
Smoking Status ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Hdl Cholesterol ◽  
Lipid Profiles ◽  
Cross Sectional ◽  
Mean Differences

Background The prevalence of smoking in adolescentstends to increase. Smoking is associated with a higher risk ofdyslipidemia.Objective To compare the lipid profiles of tobacco-smoking andnon-tobacco-smoking male adolescents.Methods We performed a cross- sectional study in three vocationalhigh schools in Yogyakarta from January to April 2011. Dataon smoking status, duration of smoking and number cigarettesconsumed per day were collected by questionnaires. We randomlyselected 50 male smokers and 50 male non-smokers as the studysubjects.Results Mean differences between smokers and non-smokerswere 44.5 (95%CI 28. 7 to 60.1) mg/dL for triglyceride levels; 8.0(95% CI 1.0 to 14.9) mg/dL for low density lipoprotein (LDL)cholesterol; 11.8 (1.1 to 22.4) mg/dL for total cholesterol and -5.7mg/dL (95% CI -8.8 to -2.6) for high density lipoprotein (HDL)cholesterol. Mean differences (95% CI) between smokers whohad engaged in smoking for > 2 years and those who had smokedfor :S:2 years were -18.1 (95% CI -33 .9 to -2.3) mg/dL for totalcholesterol; -49.4 (95% CI -67.2 to -3 1.5) mg/dL for triglycerides.Mean differences between those who smoked > 5 cigarettes/dayand :s:5 cigarettes per day were -18 .4 (95% CI -32.8 to -4.1) mg/dL for total cholesterol and -29.1 (95% CI -53.6 to -4.6) mg/dLfor triglycerides.Conclusion Smoking more than 5 cigarettes/day significantlyincreases total cholesterol, LDL cholesterol, and triglyceridelevels, as well as reduces HDL cholesterol levels; while smokingmore than 2 years significantly increases total cholesterol andtriglyceride levels

Hypolipidemic Effect ofGlycine tomentellaRoot Extract in Hamsters

2004 ◽  
Vol 32 (01) ◽  
pp. 57-63 ◽  
Author(s):  
Yu-Jen Ko ◽  
Yueh-Wern Wu ◽  
Wen-Chuan Lin
Keyword(s):  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Serum Triglyceride ◽  
Hdl Cholesterol ◽  
Cholesterol Content ◽  
High Serum ◽  
Hypolipidemic Effect ◽  
High Serum Cholesterol ◽  
Glycine Tomentella ◽  
Triglyceride Content

The influence of the aqueous crude extract of Glycine tomentella root (Leguminosae) on lipid metabolism was investigated in hyperlipidemic hamsters. It was found that the administration of the G. tomentella extract (GTE) leads to a decrease of high serum cholesterol and triglyceride levels induced by high-fat diet. The GTE also increased serum high-density lipoprotein (HDL) cholesterol and decreased serum low-density lipoprotein (LDL) cholesterol. The reduction of serum triglyceride levels was accompanied by a significant decrease in the hepatic triglyceride content, while the cholesterol content was not changed. The results indicate that GTE is definitely an anti-hyperlipidemic agent, at least, in animals.

scholarly journals A study of serum lipid profile in smokers and non-smokers: evaluation of role of smoking on lipid profile

2019 ◽  
Vol 7 (4) ◽  
pp. 1016
Author(s):  
Chandrashekar V. Kubihal ◽  
Hemalatha D. Naik
Keyword(s):  
Lipid Profile ◽  
Total Cholesterol ◽  
Serum Lipid ◽  
Serum Triglyceride ◽  
Blood Cholesterol ◽  
Serum Lipid Profile ◽  
Serum Triglyceride Level ◽  
Cross Sectional ◽  
Cholesterol Levels ◽  
Increased Risk

Background: Several studies have reported elevated blood cholesterol levels among persons who regularly smoke cigarettes and lowered blood cholesterol levels among persons quitting smoking. Other studies have also shown that smoking lowers high density lipoprotein level, resulting in an increased risk of coronary heart disease. Smoking also leads to increase in LDL cholesterol and triglyceride levels. The objective was to study serum lipid profile in smokers and non-smokers.Methods: A cross sectional comparative study was carried in 100 subjects. The subjects were divided into two groups. First group consisted of 25 nonsmokers and second group of 75 smokers. The group of 75 smokers was again divided into three equal sub groups of 25 each depending upon the duration and intensity of smoking. Concentration of serum total cholesterol and HDL was determined by Zak’s method. Concentration of serum LDL and VLDL cholesterol was determined by Friedwald’s formula. Concentration of serum triglyceride level was determined by enzymatic end point peroxidase coupled method.Results: All the values of lipid profile i.e., total cholesterol, triglycerides, LDL, VLDL were found to be significantly higher among the smokers compared to the non-smokers. HDL value was significantly lower among smokers. As the degree of smoking increased from mild to heavy smokers, the values of total cholesterol, triglycerides, LDL and VLDL increased. The degree of smoking was inversely proportional to HDL values i.e., the HDL value decreased as the smoking degree increased.Conclusions: Thus, it can be said based on the present study that smoking affects and deranges the lipid profile of the person.

scholarly journals Antiobesity Activity of Flavanoids Isolated from Solanum macrocarpum in Wistar Rats

2019 ◽  
pp. 1-9
Author(s):  
N. N. Ngwa ◽  
N. M. Nnam
Keyword(s):  
Total Cholesterol ◽  
Wistar Rats ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Serum Triglyceride ◽  
Hdl Cholesterol ◽  
Chow Group ◽  
Male Wistar Rats ◽  
Palatable Diet ◽  
Acclimatization Period

Aims: To correlate obesity/atherosclerosis with body mass index, serum cholesterol, serum triglyceride, serum low density lipoprotein   and serum high density lipoprotein of diet induced obese wistar rats. Study Design: Department of Home Science, Nutrition and Dietetics (Animal research house) and Department of veterinary science both in University of Nigeria Nsukka. The study was conducted between January to March 2012. Methodology: Four groups of twenty male Wistar rats were fed a highly palatable diet for 2 weeks to induce obesity resembling mild obesity condition in human population after one week acclimatization period. DIO rats received rat chow and flavonoids extract daily for 6 weeks. Group 1 received rat chow alone; Group 2- 0.05% of flavonoids extract and rat chow; Group 3- 0.15% of flavonoid extract and rat chow; and Group 4- 0.25% of flavonoid extract and rat chow. BMI, Total cholesterol, HDL, LDL and Triglyceride were evaluated using standard assay technique. The data were statistically analyzed using ANOVA and mean separated using LSD. Results: Feeding the rats with palatable diet showed increased in BMI (from 0.35-0.40 to 0.60-0.65), total cholesterol, LDL and triglyceride levels along with decrease in HDL (p<0.05). Consumption of flavonoids resulted in the significant reduction in BMI, LDL, total cholesterol and triglyceride level and exhibit significant elevation in  HDL cholesterol compared to the rats fed only rat chow (p<0.05). It was observed that the decrease in BMI, Triglyceride, total  cholesterol and LDL cholesterol level of rats fed 0.25% of flavonoids were significantly different (p<0.05) from those fed 0.15% and 0.05% flavonoids. Conclusions: The results suggest that flavonoids extract from Solanum macranthum has atherogenic effect which can help to reduce obesity.

Sign in / Sign up

Export Citation Format

Share Document